Abstract Cannabinoids, the bioactive constituents of Cannabis sativa, and endocannabinoids, among which the most important are anandamide and 2-arachidonoylglycerol, control various biological processes by binding to specific G protein-coupled receptors, namely CB1 and CB2 cannabinoid receptors. While a vast amount of information on the mammalian endocannabinoid system does exist, few data have been reported on bony fish. In the goldfish, Carassius auratus, the CB1 receptor has been cloned and its distribution has been analyzed in the retina, brain and gonads, while CB2
Introduction
The endocannabinoid system comprises several components, among which are specific seven transmembranedomain receptors, namely CB1 and CB2 cannabinoid receptors, and their exogenous (e.g., D 9 -tetrahydrocannabinol) and endogenous ligands (e.g., anandamide and 2-arachidonoylglycerol). CB1 are the most abundant G protein-coupled receptors (GPCR) in mammalian CNS and they mediate the majority of cannabinoid central actions (Herkenham et al. 1990; Piomelli 2003) , although recently CB1 were also found in peripheral organs (for a review, see Mackie 2008) . CB2 were originally characterized in the mammalian immune system (Munro et al. 1993 ) and more recently were described in the gonads (Grimaldi et al. 2009 ) and in the CNS (Van Sickle et al. 2005; Ashton et al. 2006; Beltramo et al. 2006; Gong et al. 2006; Onaivi et al. 2006) . The original idea that the CB1 receptor exerts physiological functions almost exclusively in the brain and CB2 in the immune system has thus evolved into the concept that in mammals both cannabinoid receptors are involved in the control of central and peripheral functions, such as neural development, neurotransmission and inflammation, cardiovascular, respiratory and reproductive functions, hormone release and action, bone formation and energy metabolism (for a review, see ).
CB1 and CB2 cannabinoid receptors have been described in almost all the vertebrate classes and also in urochordates and cephalochordates, but not in the nonchordate invertebrate phyla, thus suggesting that they are unique to the phylum of Chordata (for a review, see Elphick 2012) . CB1 and CB2 are paralogs originated by an evolutionarily ancient duplication of a common ancestral gene. Interestingly, in teleosts, duplicate copies of CB1 or CB2 gene are present, possibly as a consequence of a whole genome duplication that occurred in an ancestor of teleost fish, followed by the specific loss of a duplicate gene. Thus, in F. rubripes, two CB1 receptor genes were identified (Yamaguchi et al. 1996) , while only one CB2 gene was found (Elphick 2002) . In zebrafish, on the other hand, only one CB1 gene has been detected (Lam et al. 2006) , while two CB2 genes (CB2A and CB2B) are present (Rodriguez-Martin et al. 2007) . In goldfish, a CB1 sequence has been cloned (Valenti et al. 2005; Cottone et al. 2005 ) and the distribution of the receptor has been analyzed in the retina (Yazulla et al. 2000) , CNS (Valenti et al. 2005; Cottone et al. 2005) and gonads (Cottone et al. 2008) . On the other hand, CB2 had not yet been identified in goldfish.
In the present paper, we cloned and characterized the Carassius auratus CB2 receptor; moreover, we analyzed and compared CB1 and CB2 mRNA expression profiles in different goldfish organs.
Materials and methods

Animals
Commercially supplied C. auratus adult specimens (n = 12) of both sexes were deeply anesthetized with tricaine methanesulfonate (1:1000, MS222, Sandoz Ltd, Cham, Switzerland) under the guidelines established by the Italian law and the European Communities Council Directive (86/609/EEC) for animal welfare. The brain, gut, gonads, heart, liver, kidney, spleen, muscle, retina, gills were rapidly dissected out, immediately frozen in liquid nitrogen and stored at -80°C until use.
Cloning and sequence analysis of goldfish CB2 partial coding sequence Total RNA was extracted from the spleen of two animals, using the TRI ZOL reagent (Invitrogen, Rockville, USA) and following manufacturer's instructions. DNA contaminants were eliminated using TURBO DNA-free kit (Applied Biosystems, Foster City, USA). cDNA was synthesized from total RNA by using Multiscribe RT (Applied Biosystems) and random nonamers. C. auratus CB2 cDNA was amplified using primers specific for Danio rerio CB2A/B nucleotide sequences (available at GenBank database). The 5 0 sense primer, corresponding to zebrafish CB2 bases 437-456 (considering position 1 as the first nucleotide of the coding sequence), was as follows: 5 0 -TTT GCA TCT ACC AGG CTT CC-3 0 ; the 3 0 antisense primer, corresponding to zebrafish CB2 bases 797-816, had the following sequence: 5 0 -CAG GAT TAG AAG GAT CAA AC-3 0 . PCR was performed for 40 cycles, at 45°C annealing temperature, using Hot Start AmpliTaq Gold360 polymerase (Applied Biosystems). The 380-bp amplification product was cloned into pGEM-T-easy vector, using pGEM-T-easy Vector System (Promega, Madison, USA). Escherichia coli JM109 high efficiency competent cells (Promega) were transformed and recombinant colonies were identified by blue/white color screening and restriction digestion; 6 selected recombinant clones (pGEM-T-easy-CB2Car) were sequenced. The nucleotide sequence of the cloned C. auratus CB2 340-bp fragment is available at GenBank (accession number: GU012004). CB2 partial amino acid sequence (113 aa) was then deduced. The nucleotide and the amino acid sequence of goldfish CB2 were aligned with other known CB2 sequences, using LALIGN and ClustalW multiple alignment computer programs. Moreover, the goldfish CB2 fragment was aligned with the goldfish CB1 partial coding sequence already cloned by us Valenti et al. 2005 ).
Phylogenetic analysis
The goldfish CB2 partial amino acid sequence and the CB2 sequences of other vertebrates were aligned using ClustalW multiple alignment program and a phylogenetic tree was constructed using the NeighbourJoining method (Saitou and Nei 1987) .
Western-blotting analysis
Total proteins were extracted from goldfish spleen by using a boiling buffer containing 2.5 % sodium dodecyl sulfate and 125 mM Tris-HCl, pH 6.8. The protein concentration was determined by means of the bicinchoninic acid technique (Pierce, Rockford, USA); 100 lg of total proteins was loaded on a 10 % polyacrylamide gel, separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then blotted onto a polyvinylidene difluoride membrane (Amersham Biosciences, Little Chalfont, UK). Western-blotting was performed by using as a primary antibody an affinitypurified polyclonal antiserum raised against the N-terminus of the rat CB2 (first 30 amino acids: MAGC RELELTNGSNGGLEFNPMKEYMILSD), diluted 1:600 in Tris-buffered saline (TBS), 5 % bovine serum albumin (BSA). As a control, the anti-CB2 antibody was preadsorbed for 24 h at 4°C with the corresponding immunizing fusion protein (10 lg/ml). After the incubation with an anti-rabbit IgG horseradish peroxidase-linked antiserum, the reaction was revealed with the ECL Plus Western blotting detection reagent (Amersham Biosciences) and Kodak BioMax MR Film (Kodak, Rochester, USA). The GelDoc gel documentation system and the software Quantity One (Bio-Rad Laboratories, Hercules, USA) were used to determine the molecular weight of the specific CB2 bands on the basis of the migration of the Page Ruler Plus Prestained Protein Ladder (Fermentas, Glen Burnie, USA).
qReal-Time PCR Total RNA was isolated, as described above, from 11 different organs (brain, gut, ovary, testis, heart, liver, kidney, spleen, muscle, retina, gills) of 6 goldfish. cDNA was synthesized and amplified using the SybrGreen chemistry and Applied Biosystem 7500 thermal cycler. In particular, 2 ng (for CB1 and ß-actin) and 40 ng (for CB2) of cDNA were used for the amplification; three replicates of each reaction were performed. The primers specific for goldfish CB1, CB2 and ß-actin (used as housekeeping gene) were designed by using Primer3 software, on the basis of the sequences available at GenBank database (accession numbers: AY674057, GU012004 and AB039726, respectively), and were as follows: CB1 5 (Bustin 2000) , and was maximum (E = 2) for all the three genes. qReal-Time PCR was performed by Microarray Service, CRIBI, University of Padua, Italy.
Relative gene expression was determined using the 2 -DDCt method, as reported previously (Livak and Schmittgen 2001) , using the b-actin Ct value to normalize CB1 or CB2 Ct values. Brain and spleen were used as reference organs for CB1 and CB2, respectively. In order to compare CB1 and CB2 in the same organ, CB2 Ct values were corrected to compensate for the different starting amount of amplified cDNA (theoretical difference of 4.3 cycles).
Statistical analysis
The 2
-DDCt values obtained for CB1 or CB2 for all the organs were analyzed with a GLM (general linear model) for repeated measures, followed by Sidak post hoc test. Differences in CB1 and CB2 expression in the same organ were analyzed with t test; differences were considered statistically significant when p B 0.05. Fish Physiol Biochem (2013 ) 39:1287 -1296 1289
Results
Molecular cloning and characterization of goldfish CB2 receptor
The goldfish CB2 central region was amplified from spleen homogenates by means of RT-PCR, using primers specific for zebrafish CB2A/B nucleotide sequences, at very permissive amplification conditions. In all the 6 recombinant colonies analyzed, the cloned sequence was identical; the 340-bp goldfish CB2 partial coding sequence and the deduced 113 amino acid sequence were submitted to GenBank (accession number: GU012004). Figure 1 shows the alignment of the deduced CB2 amino acid sequence of goldfish and the other known CB2 sequences from vertebrates. As shown in Table 1a , the goldfish CB2 partial coding sequence presents a quite high degree of amino acid identity with zebrafish CB2A and CB2B (80.5 and 81.4 %, respectively), while the percentage of identity is only 57.5 % with the puffer fish F. rubripes CB2 and it becomes much lower when compared with mammalian CB2 sequences (about 38 %). By aligning goldfish CB2 and CB1 amino acid sequences, an identity of only 40.7 % was found. The percentage of identity among the different sequences was generally higher when comparing the nucleotide sequences instead of the amino acid sequences (Table 1b) . Based on the alignment of CB2 amino acid sequences from various species, the phylogenetic relationships of CB2 receptors were estimated and a phylogenetic tree was constructed using the Neighbour-Joining method (Fig. 2) . In order to better characterize goldfish CB2 receptor and to confirm CB2 expression at the protein level, spleen samples, already characterized to express CB2 mRNA (see above), were used to perform Westernblotting experiments (Fig. 3) . By using as a primary antibody an affinity-purified polyclonal antiserum raised against the N-terminus of the rat CB2, two major bands of about 53 and 40 kDa were observed. In addition, other weak bands with apparent molecular weights around 70, 57 and 55 kDa were faintly visible. When the anti-CB2 antibody preadsorbed with the corresponding immunizing fusion protein was used, no bands were observed.
CB1 and CB2 mRNA expression profiles in different goldfish organs
The expression of both CB1 and CB2 mRNAs was determined by qReal-Time PCR in the following organs of single animals (n = 6): brain, gut, ovary, testis, heart, liver, kidney, spleen, muscle, retina, gills.
As shown in Fig. 4a , following post hoc tests, the 2 -DDCt values for CB1 mRNA show several statistically significant variations among different organs. Abundant CB1 transcripts were found in brain, gills and liver, while they were much lower in retina, muscle and ovary. In the ovary, CB1 expression was in fact about 52-fold lower than in the brain (p B 0.01), used as reference organ, about 24-fold lower than in the gut (p B 0.01) and 82-fold lower than in the gills (p B 0.01). CB1 mRNA expression in the retina was about 10-fold lower than in the brain (p B 0.01) and 16-fold lower than in the gills (p B 0.01). In the spleen, CB1 mRNA levels were about threefold lower than in the gills (p B 0.05).
Concerning CB2 expression (Fig. 4b) , the highest values were found in gills, liver and kidney, the lowest in ovary, muscle and retina; some statistically significant variations in CB2 mRNA expression among different organs were found. In particular, in the ovary, CB2 expression was about 21-fold lower than in the gut (p B 0.01). CB2 mRNA expression in the retina was about sevenfold lower than in the gut (p B 0.05) and 30-fold lower than in the gills (p B 0.05).
In order to compare CB1 and CB2 transcript levels in the same goldfish organ, the expression of CB2 mRNA was referred to that of CB1 in the brain, considering the different starting amount of cDNA used for each of the two receptors. As shown in Fig. 4c , in all the investigated organs, CB2 mRNA levels are much lower than CB1 levels, in particular in the brain (about 14-fold lower, p B 0.01), as well as in the gut and in the gills (in both cases about fourfold lower, p B 0.05); also, in liver, heart and spleen, CB2 expression is markedly lower than CB1 expression, although differences did not result statistically significant.
Discussion
In order to better characterize the endocannabinoid system in the goldfish, in the present paper, the CB2 cannabinoid receptor was cloned from lysates of spleen that in mammals is known to be rich in CB2 protein and is normally used as a positive control when studying CB2 expression (Ashton et al. 2006; Matias et al. 2002; Van Sickle et al. 2005; Gong et al. 2006 ). The goldfish CB2 partial coding sequence presents the highest degree of amino acid identity with zebrafish CB2A and CB2B receptors (over 80 %), while the percentage of identity is lower with the puffer fish F. rubripes (57.5 %) and quite low with mammalian CB2 sequences (about 38 %). Although these data are only indicative, since only a part of the goldfish CB2 Fig. 1 ). The higher sequence identity between the goldfish and the zebrafish CB2 sequences, compared to F. rubripes, is confirmed by the lower phylogenetic distance between the CB2 receptors of the first two species and is in agreement with the fact that goldfish and zebrafish are phylogenetically closer, since both are members of the Cyprinidae family, while F. rubripes belongs to Tetraodontida. By aligning goldfish CB2 and CB1 partial amino acid sequences, an identity of only 40.7 % was found. This result is in agreement with data found in mammals, where, for example, an identity of about 44 % was found between human CB1 and CB2, thus pointing to a very early separation of the two encoding genes during phylogeny. The fact that the sequence we cloned is much more similar to the D. rerio CB2A/B sequence compared to the C. auratus CB1 sequence strongly reduces the possibility of having isolated a fragment or an isoform of goldfish CB1 and confirms the actual cloning of part of the CB2 receptor.
Comparing the zebrafish CB2A and CB2B regions corresponding to the cloned goldfish CB2 sequence, as much as 7 different nucleotides can be found. This observation, together with the fact that no differences in the nucleotide sequence were found among the 6 goldfish clones analyzed, suggests that only one CB2 gene exists in C. auratus, consistently with what found in F. rubripes and Tetraodon nigroviridis Egertovà 2001, 2009 ). The existence of two CB2 genes in zebrafish and of just one CB2 gene in other bony fish may actually reflect the specific loss of a duplicate gene after a whole genome duplication that Fig. 2 Phylogenetic analysis of vertebrate CB2 cannabinoid receptors. The phylogenetic tree was constructed using the Neighbour-Joining method. Branch lengths are proportional to the estimated evolutionary distances among the receptors Fig. 3 Western-blotting analysis of goldfish spleen lysates. By using an anti-CB2 antibody, two major bands of about 53 and 40 kDa are observed, together with other faint bands with apparent molecular weights around 70, 57 and 55 kDa. The preadsorption of the antibody with the corresponding immunizing fusion protein (C-) gives no bands occurred in an ancestor of teleost fish (Elphick and Egertová 2009 ). However, we cannot definitively exclude the existence in goldfish of a CB2 paralog gene having a sequence divergent enough that the primers used in the present work were not able to recognize it. The fact that the whole genome sequence of goldfish is still unknown precludes in this species the use of the genome sequence analysis techniques usefully employed to search CB2 genes in other fish (Elphick 2002; Rodriguez-Martin et al. 2007 ). In order to better characterize the goldfish CB2 receptor and to confirm CB2 expression at the protein level, Western-blotting experiments were performed on spleen lysates, already demonstrated to contain CB2 mRNA. Two major bands of 53 and 40 kDa and very weak bands with apparent molecular weights of about 70, 57 and 55 kDa were detected. Since the complete coding sequence of goldfish CB2 is still unknown, it is not yet possible to calculate the CB2 receptor molecular weight on the basis of its amino acid sequence. However, the predicted size of the CB2 protein is about 43 kDa in D. rerio and 42 kDa in F. rubripes, while it is about 39 kDa in human, rat and mouse. The 40 kDa band observed in goldfish could therefore correspond to the posttranslationally unmodified CB2 receptor, while the other bands could possibly be differently glycosylated forms. Alternatively, the two major bands of 53 and 40 kDa could represent two alternative spicing forms of the goldfish CB2 gene. Since an antibody against fish CB2 is not available, in the present experiments, we used an anti-CB2 antibody raised against the N-terminus of rat CB2. The nucleotide sequence corresponding to the goldfish CB2 N-terminus has not been cloned; therefore, it is not possible to anticipate its degree of interaction with the antibody used in this study. However, it is known from other studies that the primary amino acid sequence of the CB2 N-terminus in mammals and in D. rerio and F. rubripes differs significantly. Therefore, the possibility of a crossreaction with goldfish proteins other than CB2 cannot be excluded. The gold standard to demonstrate the antiserum specificity in goldfish tissues would be to use CB2 knockout goldfish, but unfortunately these do not exist. We can, however, consider our immunoblotting results as a first step toward the full characterization of the CB2 protein in goldfish for at least two considerations. First, we tested the epitope specificity by performing antibody preadsorption studies, finding no bands. Second, our results on the CB2 protein in goldfish are consistent with those obtained in mammals, and to the best of our knowledge, similar experiments have not yet been done in other bony fish. Western-blotting analysis on human immature dendritic cells shows the presence of three immunoreactive bands of about 59, 45 and 39 kDa (Matias et al. 2002) . In rat, bands of about 59, 47 and 39 kDa were observed in spleen lysates (Matias et al. 2002) and bands of 60, 55, and 44 kDa were found in brain lysates (Van Sickle et al. 2005) . In mouse brain and spleen, a major band of approximately 53 kDa was revealed, together with other bands around 75 and 37 kDa .
Since the localization of a receptor could give important information on its physiological role, we analyzed the expression of both CB1 and CB2 cannabinoid receptor mRNAs in different organs of the goldfish, namely brain, gut, ovary, testis, heart, liver, kidney, spleen, muscle, retina and gills. Abundant CB1 transcripts were found in brain, gills and liver, while they were much lower in retina, muscle and ovary. In some organs (i.e., muscle, spleen, kidney), CB1 mRNA levels presented considerable variations among samples, possibly because of animal variability and the limited number of goldfish specimen analyzed. CB1 receptor expression has been widely investigated in the CNS of vertebrates, both in adults and during embryogenesis; on the other hand, only a few studies on its presence in peripheral districts are known. In goldfish, CB1 receptors have been reported in retina (Yazulla et al. 2000) , brain Valenti et al. 2005 ) and gonads (Cottone et al. 2008) . In zebrafish, CB1 distribution was analyzed in the CNS (Lam et al. 2006) , while in F. rubripes, CB1 receptors have been described to be highly expressed in the brain and to a much lesser extent in the spleen, ovary and testis (Yamaguchi et al. 1996) . In mammals, CB1 receptors, although more abundant in the CNS, were also described in the pituitary (Gonzales et al. Gonzalez et al. 1999; Wenger et al. 1999; Pagotto et al. 2001; Cesa et al. 2002) , retina (Straiker et al. 1999; Yazulla et al. 1999 Yazulla et al. , 2000 Porcella et al. 2000; Yazulla and Studholme 2001) and peripheral organs, such as the reproductive system (Gerard et al. 1991) , immune system (Kaminski et al. 1992; Bouaboula et al. 1993; Galiègue et al. 1995) , gastrointestinal apparatus, heart, muscle (Gebremedhin et al. 1999) , urinary bladder, adrenal glands and lung (Rice et al. 1997 ). However, no study was conducted to quantify and compare CB1 levels in the different organs.
Concerning CB2 expression, in the goldfish, we found high mRNA levels in gills, liver and kidney, while low values were detected, as for CB1 receptor, in the ovary, muscle and retina. Among bony fish, CB2 distribution has been evaluated by in situ hybridization and nonquantitative RT-PCR in some organs of the zebrafish (Rodriguez-Martin et al. 2007 ). The authors noticed a somewhat different expression of CB2A and CB2B mRNA in the various organs, but in general, CB2 was found to be expressed in spleen, brain (where, however, ISH failed to reveal any specific labeling), pituitary, intestine, retina, gill and heart; a very weak band corresponding to CB2 was observed in muscle. Our results concerning CB2 expression in goldfish are in agreement, at least in part, with the data obtained in mammals by using RT-PCR, Northernblotting and immunohistochemical techniques. High CB2 levels were in fact demonstrated in mammals in spleen and tonsils, both enriched in B lymphocytes, and, in lower quantities, in heart, lung, thymus and brain. However, in contrast with the present results in goldfish, the mammalian CB2 receptors seem to be absent in the liver, kidney and muscle (Galiègue et al. 1995; Van Sickle et al. 2005; Ashton et al. 2006; Beltramo et al. 2006; Gong et al. 2006; Onaivi et al. 2006) .
When CB1 and CB2 mRNA levels were compared in the same goldfish organ, CB2 levels were always lower than CB1 levels. The difference was particularly strong in the brain, in line with the fact that CB1 receptors do exert a pivotal role in modulating central functions, such as locomotion, learning, memory, nociception, while CB2 receptors could have more restricted functions.
In conclusion, the present study deepens the understanding of the endocannabinoid system in goldfish and represents, to the best of our knowledge, the first approach to quantify and compare CB1 and CB2 cannabinoid receptor expression in the different organs of a nonmammalian vertebrate. Since much can be learned about the physiological role of the receptors by determining their distribution, our results could encourage further studies shedding light on the functional roles of the endocannabinoid system in bony fish and other nonmammalian vertebrates.
